- September 7 (THU)
- September 8 (FRI)
Sep. 7 (Thu)
Satellite Symposium 1 (SL01)
| Date & Time |
September 7 (Thu), 08:40-09:20 |
Venue |
Room B |
| Chair |
- Young Joo Min (Ulsan University Hospital, Republic of Korea)
|
| Session Details |
- Pembrolizumab and chemotherapy combinations, the global SOC in the 1st line treatment for NSCLC, HNSCC, and esophageal cancer
Ji-Hyun Park (Konkuk University Medical Center, Republic of Korea)
|
Satellite Symposium 2 (SL02)
New era of 1st-line treatment for GC/GEJ/EAC with Nivolumab
| Date & Time |
September 7 (Thu), 09:30-10:10 |
Venue |
Room B |
| Chair |
- Min-hee Ryu (Asan Medical Center, Republic of Korea)
|
| Session Details |
- 1. Real-World Practice of PD-L1 Testing for Nivolumab Plus Chemotherapy in Gastroesophageal Adenocarcinoma
Hye Seung Lee (Seoul National University Hospital, Republic of Korea)
- 2. New Era of 1L Treatment for HER2 negative GC / GEJC / EAC with Nivolumab
Min Kyu Jung (Yonsei Cancer Center, Republic of Korea)
|
Luncheon Symposium 1 (LS01)
| Date & Time |
September 7 (Thu), 11:30-12:10 |
Venue |
Room A |
| Chair |
- Sang-we Kim (Asan Medical Center, Republic of Korea)
|
| Session Details |
- Latest advances in small cell lung cancer treatment
Hyun Ae Jung (Samsung Medical Center, Republic of Korea)
|
Luncheon Symposium 2 (LS02)
| Date & Time |
September 7 (Thu), 11:30-12:10 |
Venue |
Room C |
| Chair |
- Kyung Hae Jung (Asan Medical Center, Republic of Korea)
|
| Session Details |
- Evolution and future of ribociclib in HR+HER2- mBC treatment
Ji Yeon Kim (Samsung Medical Center, Republic of Korea)
|
Luncheon Symposium 3 (LS03)
| Date & Time |
September 7 (Thu), 11:30-12:10 |
Venue |
Room E |
| Chair |
- Joo Hyuk Sohn (Yonsei University College of Medicine, Republic of Korea)
|
| Session Details |
- Change HER Destiny: Implementing ENHERTU in Practice and Practical Considerations
Jae Ho JEONG (Asan Medical Center, Republic of Korea)
|
Satellite Symposium 3 (SL03)
| Date & Time |
September 7 (Thu), 12:30-13:10 |
Venue |
Room B |
| Chair |
- Keun Seok Lee (National Cancer Center, Republic of Korea)
|
| Session Details |
- Optimizing efficacy, safety and QOL balance of CDK 4/6 inhibitors in treating HR+/HER2- breast cancer patients
Jieun LEE (The Catholic University of Korea Seoul St. Mary's Hospital, Republic of Korea)
|
Satellite Symposium 4 (SL04)
| Date & Time |
September 7 (Thu), 13:20-14:00 |
Venue |
Room B |
| Chair |
- Jae Lyun Lee (Asan Medical Center, Republic of Korea)
|
| Session Details |
- The first ADC in la/mUC treatment, Enfortumab Vedotin landed in Korea
In-Ho Kim (The Catholic University of Korea Seoul St. Mary's Hospital, Republic of Korea)
|
Collaborative Symposium
Antibody-drug conjugates: Rise of new therapeutic strategies
| Date & Time |
September 7 (Thu), 14:10-14:50 |
Venue |
Room B |
| Chair |
- Solange Peters (Lausanne University Hospital, Switzerland)
|
| Session Details |
- 1. Current and future perspectives on ADC strategies
Solange Peters (Lausanne University Hospital, Switzerland)
- 2. Directing therapies to integrins in solid tumors
Hyun Cheol Chung (Yonsei Cancer Center, Republic of Korea)
|
Satellite Symposium 5 (SL05)
| Date & Time |
September 7 (Thu), 16:30-17:10 |
Venue |
Room B |
| Chair |
- Jong Gwang Kim (Kyungpook National University Chilgok Hospital, Republic of Korea)
|
| Session Details |
- Recent update in study for pattern, efficacy and safety of use of Bevacizumab or Cetuximab in patients with metastatic colorecatal cancer when added to FOLFIRI treatment
Seung Hoon Beom (Yonsei Cancer Center, Republic of Korea)
|
Satellite Symposium 6 (SL06)
A new perspectives & future paradigm shift of treatment for advanced gastric cancer
| Date & Time |
September 7 (Thu), 17:20-18:00 |
Venue |
Room B |
| Chair |
- Dae Young Zang (Hallym University Sacred Heart Hospital, Republic of Korea)
|
| Session Details |
- 1. How do we treat Advanced Gastric Cancer: biomarkers discovery and future systemic therapies?
Jin-Soo Kim (Seoul National University BORAMAE Medical Center, Republic of Korea)
- 2. 2023 PRODIGY update: Role of Neoadjuvant with DOS regimen in locally advanced gastric cancer
Hyung-Don Kim (Asan Medical Center, Republic of Korea)
|
Sep. 8 (Fri)
Satellite Symposium 7 (SL07)
| Date & Time |
September 8 (Fri), 08:00-08:40 |
Venue |
Room A |
| Chair |
- JoungSoon JANG (Uijeongbu Eulji Medical Center, Eulji Univeristy, Republic of Korea)
|
| Session Details |
- State-of-the-art Neo/Adjuvant treatment in pancreatic cancer: Guidance for oncologist
Chung Ryul Oh (Chung-Ang University Hospital, Republic of Korea)
|
Satellite Symposium 8 (SL08)
| Date & Time |
September 8 (Fri), 08:00-08:40 |
Venue |
Room C |
| Chair |
- Myung Ah Lee (The Catholic University of Korea Seoul St. Mary’s Hospital, Republic of Korea)
|
| Session Details |
- Navigating the role of Lenvatinib in hepatocellular carcinoma : An up-to-date data review and emerging treatment strategies
Jaekyung Cheon (Asan Medical Center, Republic of Korea)
|
Satellite Symposium 9 (SL09)
Where are we from a perspective of patient centricity in terms of Flexcare?
| Date & Time |
September 8 (Fri), 08:00-08:40 |
Venue |
Room D |
| Chair |
- Yeon Hee Park (Samsung Medical Center, Republic of Korea)
|
| Session Details |
- HER2+ Breast Cancer: Adjuvant Pertuzumab and Patient-Centric Care
Elaine Lim (National Cancer Center Singapore, Singapore)
|
Satellite Symposium 10 (SL10)
| Date & Time |
September 8 (Fri), 08:00-08:40 |
Venue |
Room E |
| Chair |
- Hei-Cheul Jeung (Gangnam Severance Cancer Hospital, Republic of Korea)
|
| Session Details |
- Treatment for metastatic colorectal cancer : Focused on FTD/TPI
Kyung Hye Bang (Chung-Ang University Gwangmyeong Hospital, Republic of Korea)
|
Satellite Symposium 11 (SL11)
| Date & Time |
September 8 (Fri), 10:00-10:40 |
Venue |
Room B |
| Chair |
- Seock-Ah Im (Seoul National University Hospital, Republic of Korea)
|
| Session Details |
- Addressing unmet needs in the treatment of patients with metastatic triple-negative breast cancer
Adam Brufsky (Comprehensive Breast Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh, University of Pittsburgh, USA)
|
Satellite Symposium 12 (SL12)
| Date & Time |
September 8 (Fri), 10:50-11:30 |
Venue |
Room B |
| Chair |
- Ji-Youn Han (National Cancer Center, Republic of Korea)
|
| Session Details |
- Recent advances in targeting EGFR exon 20 mutations in non–small cell lung cancer: Mobocertinib
Sun Min Lim (Yonsei University College of Medicine, Republic of Korea)
|
Luncheon Symposium 4 (LS04)
| Date & Time |
September 8 (Fri), 11:40-12:20 |
Venue |
Room A |
| Chair |
- Seong-Hoon SHIN (Kosin University Gospel Hospital, Republic of Korea)
|
| Session Details |
- More TOMORROWs for her: Pembrolizumab, the cutting edge in women’s cancer
Soo jung Lee (Kyungpook National University Chillgok Hospital, Republic of Korea)
|
Luncheon Symposium 5 (LS05)
| Date & Time |
September 8 (Fri), 11:40-12:20 |
Venue |
Room C |
| Chair |
- Kyong Hwa Park (Korea University Anam Hospital, Repubic of Korea)
|
| Session Details |
- Long-term outcome of abemaciclib in HR+, HER2 - high-risk early breast cancer
In Hae Park (Korea University Guro Hospital, Republic of Korea)
|
Luncheon Symposium 6 (LS06)
| Date & Time |
September 8 (Fri), 11:40-12:20 |
Venue |
Room D |
| Chair |
- Ki Hyeong LEE (Chungbuk National University Hospital, Republic of Korea)
|
| Session Details |
- Lazertinib: Redefining the treatment journey in EGFR mutant NSCLC - From 1st line
Byoung Chul CHO (Severance Hospital, Republic of Korea)
|
Satellite Symposium 13 (SL13)
| Date & Time |
September 8 (Fri), 12:40-13:20 |
Venue |
Room B |
| Chair |
- Joon Oh Park (Samsung Medical Center, Republic of Korea)
|
| Session Details |
- Optimizing Treatment for Patients with Metastatic Pancreatic Cancer
Jeesun Yoon (Seoul National University Hospital, Republic of Korea)
|
Master Class (MC)
When common cancer meets NGS
| Date & Time |
September 8 (Fri), 12:40-14:20 |
Venue |
Room D |
| Chairs |
- Jin Seok Ahn (Samsung Medical Center, Republic of Korea)
|
| Session Details |
- 1. KRAS mutation: How should we act on it?
Sun Min Lim (Yonsei University College of Medicine, Republic of Korear)
- 2. MET-targeted therapies – About time we MET
Tae Min Kim (Seoul National University Hospital, Republic of Korea)
- 3. New targeted therapies for EGFR exon 20 insertion
Beung Chul Ahn (National Cancer Center, Republic of Korea)
- 4. RET fusion as a novel actionable target in NSCLC
Min Hee Hong (Yonsei Cancer Center, Republic of Korea)
|
Satellite Symposium 14 (SL14)
| Date & Time |
September 8 (Fri), 16:10-16:50 |
Venue |
Room B |
| Chair |
- Sun Young KIM (Asan Medical Center, Republic of Korea)
|
| Session Details |
- Digital solutions for precision medicine - Highly curated genomic analysis platform
Cindy Shen HUANG (Roche Diagnostics, APAC Region, Taiwan)
|
Satellite Symposium 15 (SL15)
| Date & Time |
September 8 (Fri), 17:00-17:40 |
Venue |
Room B |
| Chair |
- Se Hoon Park (Samsung Medical Center, Republic of Korea)
|
| Session Details |
- Real World data and treatment experience with Avelumab in patients with locally advanced or metastatic urothelial carcinoma; Focusing on first real world results from Korean Expanded Access Program
Inkeun Park (Asan Medical Center, Republic of Korea)
|
